Skip to main content
. 2022 Sep 14;7(9):1713–1724. doi: 10.1182/bloodadvances.2022008292

Figure 3.

Figure 3.

KIT mutations in patients with MCL. (A) Relative frequency distribution of KIT mutations in 85 patients with MCL. (B) Kaplan-Meier estimates of OS stratified by KIT D816V mutation status; and (C) stratified by KIT D816V positivity vs alternative KIT mutation positivity vs no detectable KIT mutations.